Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from National Institute for Health and Care Excellence

GP breast cancer referrals ‘miss’ 95% of under-50s who will develop the disease

Breast cancer is one of the leading causes of death in women under 50 in the UK

The Independent UK

Why Is Autolus Therapeutics Stock Trading Higher On Tuesday?

The U.K.’s National Institute for Health and Care Excellence (NICE) published on Tuesday draft guidance recommending Autolus Therapeutics plc’s (NASDAQ:AUTL) Aucatzyl (obecabtagene autoleucel, or obe-cel) for use in the National Health Service (NHS) for adult patients (≥26 years) with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL).

Benzinga

UK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment

The U.K.’s National Institute for Health and Care Excellence (NICE) is recommending a treatment from a firm jointly owned by GSK Plc (NYSE:GSK), Pfizer Inc (NYSE:PFE) and Shionogi Inc.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Nice was right to say no – for now – to new Alzheimer’s drugs

The UK’s National Institute for Health and Care Excellence (Nice) has declined to recommend two new Alzheimer’s drugs for routine NHS use in England. While disappointing for some families affected by dementia, this decision reflects a cautious and evidence-based approach that protects patients and public funds.

The Conversation

Hundreds of blood cancer patients to benefit from new treatment

Elranatamab, an injection that treats myeloma, has been recommended for NHS use by the National Institute for Health and Care Excellence.

Evening Standard

Extra pregnancy scan could slash number of breech births and risk to babies

Researchers hope their findings will lead to a change in National Institute for Health and Care Excellence guidelines.

The Independent UK

Covid-19 drug Evusheld not recommended for NHS use

The National Institute for Health and Care Excellence (NICE) said there is no clinical evidence that it protects against existing coronavirus variants

Wales Online

Read news from The Economist, FT, and more,
with one subscription

People with alcohol issues ‘slipping through the net’, health body warns

The National Institute for Health and Care Excellence said thousands could be missing out on help.

The Independent UK

Study highlights needs for NHS ear wax removal services as some struggle to hear

Nine out of 10 participants said hearing difficulty was ‘at least moderately bothersome’, the research found.

The Independent UK

Women in England with breast cancer may qualify for drug that buys ‘precious’ time

Nice approves Keytruda, which with chemotherapy can lengthen survival of women with triple negative breast cancer

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Cambridge

250 stories

Breast Cancer Now

141 stories

University of Manchester

the National Health Service

46 stories

GSK Plc

44 stories

the National Institute for Health and Care Excellence

29 stories

Evusheld

22 stories

National Institute for Health and Care Excellence

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.